Asthma patients experience respiratory distress due to allergens like house dust mites or pollen. However, the various triggers for asthma share a common pathway involving the release of proteins called type-2 cytokines by Type-2 helper T (Th2) cells and group-2 innate lymphoid cells (ILC2s). Both Th2 and ILC2 require high amounts of GATA-binding protein 3 (GATA3) for their maturation.
Protagonist’s $50M milestone; Swiss biotech raises $27M; Kymera halts a PhI
Plus, news from CEPI and ProJenX: Protagonist Therapeutics records a $50M milestone: The company said Wednesday that it’s getting a $50 million milestone from its